[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO1991008771A3 - Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes - Google Patents

Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes Download PDF

Info

Publication number
WO1991008771A3
WO1991008771A3 PCT/FR1990/000934 FR9000934W WO9108771A3 WO 1991008771 A3 WO1991008771 A3 WO 1991008771A3 FR 9000934 W FR9000934 W FR 9000934W WO 9108771 A3 WO9108771 A3 WO 9108771A3
Authority
WO
WIPO (PCT)
Prior art keywords
exoantigens
antigens
preparing
strains
intensive
Prior art date
Application number
PCT/FR1990/000934
Other languages
English (en)
Other versions
WO1991008771A2 (fr
Inventor
Joseph Schrevel
Andre Gorenflot
Eric Precigout
Alain Marchand
Philippe Brasseur
Hostis Monique L
Daniel Rigomier
Alexis Francois Marie Valentin
Emmanuel Vidor
Guy Bissuel
Original Assignee
Rhone Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Merieux filed Critical Rhone Merieux
Publication of WO1991008771A2 publication Critical patent/WO1991008771A2/fr
Publication of WO1991008771A3 publication Critical patent/WO1991008771A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/947—Microorganisms using protozoa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne un procédé de culture de Babesia divergens, caractérisé en ce que la souche de Babesia est maintenue en culture sur un milieu de culture exempt de protéine sérique mais contenant des lipoprotéines ainsi que des hématies, ainsi qu'un procédé de préparation d'exoantigènes et un vaccin contenant ces antigènes.
PCT/FR1990/000934 1989-12-20 1990-12-20 Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes WO1991008771A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR89/16890 1989-12-20
FR898916890A FR2655853B1 (fr) 1989-12-20 1989-12-20 Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.

Publications (2)

Publication Number Publication Date
WO1991008771A2 WO1991008771A2 (fr) 1991-06-27
WO1991008771A3 true WO1991008771A3 (fr) 1991-08-08

Family

ID=9388758

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1990/000934 WO1991008771A2 (fr) 1989-12-20 1990-12-20 Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes

Country Status (8)

Country Link
US (1) US5290688A (fr)
EP (1) EP0460177A1 (fr)
AU (1) AU641723B2 (fr)
FR (1) FR2655853B1 (fr)
IE (1) IE904638A1 (fr)
PT (1) PT96273A (fr)
WO (1) WO1991008771A2 (fr)
ZA (1) ZA9010116B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724392B1 (fr) * 1994-09-08 1996-12-13 Virbac Lab Procedes de culture, d'attenuation de la virulence et de clonage in vitro de parasites du genre babesia et leurs applications

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0018579A2 (fr) * 1979-04-30 1980-11-12 University of Illinois Foundation Antigène de la babésiose, vaccin et réactif de diagnostic le contenant
FR2608926A1 (fr) * 1986-12-24 1988-07-01 Secr Agricult Nord Irland Antigene de babesia divergens, procede pour le produire et vaccin le contenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055466A (en) * 1973-07-09 1977-10-25 Johnson & Johnson Culture medium for tissue culture techniques
GB2062463B (en) * 1979-11-06 1983-11-23 Commw Scient Ind Res Org Babesiosis vaccine
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
FR2589063B1 (fr) * 1985-10-24 1988-08-26 Rhone Merieux Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
ZA902546B (en) * 1989-04-04 1991-04-24 Univ Florida Novel proteins and cloned genes for diagnosis and prophylaxis of babesiosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0018579A2 (fr) * 1979-04-30 1980-11-12 University of Illinois Foundation Antigène de la babésiose, vaccin et réactif de diagnostic le contenant
FR2608926A1 (fr) * 1986-12-24 1988-07-01 Secr Agricult Nord Irland Antigene de babesia divergens, procede pour le produire et vaccin le contenant

Also Published As

Publication number Publication date
WO1991008771A2 (fr) 1991-06-27
ZA9010116B (en) 1991-09-25
FR2655853B1 (fr) 1994-06-10
EP0460177A1 (fr) 1991-12-11
FR2655853A1 (fr) 1991-06-21
AU7054791A (en) 1991-07-18
IE904638A1 (en) 1991-07-17
AU641723B2 (en) 1993-09-30
US5290688A (en) 1994-03-01
PT96273A (pt) 1991-09-30

Similar Documents

Publication Publication Date Title
AU2641588A (en) Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
EP0361991A3 (fr) Méthode de préparation microbiologique du sérum d'albumine humaine et d'autres protéines hétérologues à partir d'une levure
EP0313378A3 (fr) Méthodes et compositions pour l'elimination temporaire d'anticorps immuns humoraux
AU1347688A (en) Viral antigen, process for its production, and application in diagnosis and therapy (vaccine)
IE800858L (en) Babesiosis antigen.
EP0306219A3 (fr) Protéines et peptides du HIV pour le diagnostic, la prophylaxie et la thérapie du SIDA
ES8706824A1 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
CA2135630A1 (fr) Epitopes de proteines de vih immunologiquement homologues aux proteines de hla
DE3160264D1 (en) Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines
JPS6463392A (en) Monoclonal antibody against specific antigen for human immunodeficiency virus
AU3313789A (en) Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine
NO169820C (no) Fremgangsmaate for fremstilling av en mastittvaksine
AU2888089A (en) Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production and use of same
WO1991008771A3 (fr) Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes
EP0467972A4 (en) Rickettsial antigens for vaccination and diagnosis
FI95871B (fi) Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi
EP0381427A3 (fr) Composition de vaccin
OA08782A (en) Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies.
NZ222766A (en) Aids virus antigens: env/gag polypeptides: production by genetic engineering techniques: vaccines, and methods of diagnostic testing
AU1190388A (en) Methods and materials for hiv detection and therapy
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
AU7542287A (en) Vaccines containing epitopes of both the csp and a blood stage antigen of a plasmodium parasite
EP0309898A3 (fr) Méthode pour l'induction d'une réponse de cellule T cytotoxique
EP0345559A3 (fr) Variants du HIV-2

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991901827

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWP Wipo information: published in national office

Ref document number: 1991901827

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1991901827

Country of ref document: EP